Shelter Pharma (BOM:543963) Debt-to-Equity : 0.02 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Debt-to-Equity?

Shelter Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Shelter Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹5.7 Mil. Shelter Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹358.2 Mil. Shelter Pharma's debt to equity for the quarter that ended in Mar. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shelter Pharma's Debt-to-Equity or its related term are showing as below:

BOM:543963' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.12
Current: 0.02

During the past 4 years, the highest Debt-to-Equity Ratio of Shelter Pharma was 0.12. The lowest was 0.00. And the median was 0.02.

BOM:543963's Debt-to-Equity is ranked better than
92.55% of 846 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs BOM:543963: 0.02

Shelter Pharma Debt-to-Equity Historical Data

The historical data trend for Shelter Pharma's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Debt-to-Equity Chart

Shelter Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

0.02

0.12

0.02

Shelter Pharma Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial			0.02	N/A	0.12	0.01	0.02

Competitive Comparison of Shelter Pharma's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shelter Pharma's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shelter Pharma's Debt-to-Equity falls into.

Shelter Pharma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shelter Pharma's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.041	+	5.732)	/	358.158
	=	0.02

Shelter Pharma's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.041	+	5.732)	/	358.158
	=	0.02

Shelter Pharma (BOM:543963) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Shelter Pharma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shelter Pharma (BOM:543963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Mistry Chambers, Khanpur, Ahmedabad, GJ, IND, 380001

Website

https://www.shelter.co.in

Shelter Pharma Ltd focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. It is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. Its products include Tablets, syrups, Baby drops, Barley Water, Oils, Powders, Ointments and Etc.

Shelter Pharma (BOM:543963) Headlines

No Headlines